Supplement safety · public sources

Turmeric and curcumin safety

FDA adverse-event reports, NIH guidance on interactions, and registered trials.

What public sources say about the safety of turmeric and curcumin: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.

⚠️
Research information, not medical advice. Supplements can interact with prescription medicines and affect conditions. Check with a pharmacist or your own clinician before starting or stopping one. Nothing here is a dose recommendation.

Interactions and safety, in NIH's words

Conventionally formulated oral turmeric or curcumin (not modified to enhance bioavailability) is likely safe in the recommended amounts for up to 2 or 3 months.

Oral turmeric can cause adverse effects such as nausea and vomiting, acid reflux, stomach upset, diarrhea, or constipation. Topical curcumin can cause hives or itching.

Many curcumin products with increased bioavailability are on the market, and liver damage has been reported in some people who have consumed these bioavailable formulations. If you notice any liver damage symptoms such as fatigue, nausea, poor appetite, dark urine, or jaundice, stop consuming turmeric or curcumin products immediately and talk with your health care provider.

Quoted from the “What Do We Know About Safety?” section: NIH National Center for Complementary and Integrative Health, retrieved 2026-11-16. Read the full page for the complete list and references.

FDA adverse-event reports (CAERS)

Reports are not rates. CAERS counts voluntary reports to the FDA from consumers, clinicians and companies. A report means someone linked a health problem to a product, not that the product caused it. There is no denominator: how many people took the product is unknown, so these numbers cannot show how common a problem is, and they cannot be compared between products. Popular products attract more reports.
328reports naming it in a suspect product
247where the product is named for it alone
2009–2026years covered, single-ingredient reports

Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “TURMERIC”, “CURCUMIN”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.

Combination products: 81 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 247 reports where a product is named for turmeric and curcumin alone. This split is made from product names and can misfile some products. Most-reported products: Puritan'S Pride Turmeric Curcumin (20); Turmeric (12); Puritan'S Pride Turmeric (9); Youtheory Turmeric (6); Puritan'S Pride Turmeric Curcumin 500Mg Rapid Release Capsules (6); Puritans Pride Turmeric 400 Mg Rapid Release Capsules (5).

Most reported reactions, single-ingredient reports
Most reported reactions (single-ingredient products)Reports
Nausea29
Dizziness22
Fatigue21
Dyspnoea17
Diarrhoea16
Jaundice16
Pain16
Vomiting16
Asthenia14
Hospitalisation13
Pruritus12
Hepatic enzyme increased11

Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (139), Hospitalization (93), Visited Emergency Room (62), Visited a Health Care Provider (59), Other Serious Outcome (34), Life Threatening (25), Disability (11), Other Outcome (10).

Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.

Registered trials

147 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.

All supplement safety pages Non-drug evidence map